News
First GLP-1 tablet for weight loss approved in the UK
Source: MHRA 11.6.26 Having met the MHRA’s rigorous standards of safety, quality and effectiveness, the semaglutide tablet has been approved in the UK for weight loss and weight management. The...
Dispex Knowledge Hub – Now Easier to Navigate
We are currently updating our website to make the Members’ Pages easier to navigate and more user-friendly. One of the recent improvements is the introduction of the Dispex Knowledge section,...
Be the First to Own the 2026 Essential Dispensary Manager’s Guide
Get your copy at a special event-only rate by visiting our stand at Dispex Live in Cambridge Now featuring a brand-new chapter: CQC & Compliance in Dispensing Practice. Discover what...
Dispex Live 2026 – Everything You Need to Know!
With less than a month to go, please check out our latest Gazette covering Everything You Need to Know! Keep an eye out for further updates! Unlock your dispensary’s full...
Class 4 Medicines Defect Notification: Cadila Pharmaceuticals Limited, Mirtazapine 30mg Tablets, EL(26)A/28
Source: MHRA 08.06.26 Cadila Pharmaceuticals Limited has informed the MHRA of an error with the European Article Number (EAN) barcode on the cartons of a batch of Mirtazapine 30mg Film-Coated...
Class 4 Medicines Defect Notification: Teva UK Ltd, Ponlimsi (Denosumab) 60mg Solution for Injection in Pre-filled Syringe, EL(26)A/27
Source: MHRA 04.06.26 Teva UK Limited is reporting a labelling error on the carton for Ponlimsi (Denosumab) 60mg Solution for injection in Pre-filled Syringe. The carton states “For application to...
Class 2 Medicines Recall: Becton Dickinson UK Ltd, ChloraPrep 2% 1mL and ChloraPrep Frepp 2% 1.5mL applicators, EL(26)A/26
Source: MHRA 02.06.26 Becton Dickinson UK Ltd are recalling batches of ChloraPrep 2% 1mL applicators and ChloraPrep Frepp 2% 1.5 mL applicators due to a potential breach of sterility...
Class 2 Medicines Recall: Crescent Pharma Limited, Ramipril 2.5 mg Capsules, EL(26)A/25
Source: MHRA 28.5.26 Crescent Pharma Limited is initiating a precautionary recall of one batch of Ramipril 2.5 mg Capsules following the identification of a potential packaging error at the...
Allurion Gastric Balloon: Updated safety information due to the risks of gastric outlet obstruction, small bowel obstruction and gastric perforation (DSI/2026/004)
Source: MHRA update 27.5.2026 In rare instances, the Allurion Gastric Balloon has not transited through the stomach or bowel as intended, leading to complications such as gastric outlet obstruction, small...
Kimal Procedure Packs containing recalled components: Namic Angiographic Syringe with the risk of syringe disconnection; Namic Manifolds with the risk of foreign particulates. Important guidance for use in urgent procedures where there are no alternatives.
Updated 22.5.26 Source: MHRA 19.5.26 Medline Industries LP and Kimal PLC have identified safety issues with the Namic Angiographic Control Syringes with RA and Namic White Star Off Handle Manifold...
Risk of severe harm from use of incorrect giving (administration) set for blood transfusion (DSI/2026/003)
Source: MHRA 20.5.26 There is a potential for serious harm to patients if an intravenous (IV) infusion giving set is used instead of a blood transfusion giving set to deliver...
Busy dispensary? We’re here to help you stay on top of your training requirements.
Tutorials We understand how demanding dispensary life can be, but we also know the importance of completing training to meet your DSQS requirements. That’s why we continue to offer our...
